April_Tariff War|Tariff War Extends, Drugs Become New Concerns
Commentator: Shin Chung-chul, Director of Health Center, Ji-Pu Industrial Trend Research Institute
Under Trump's reciprocal tariffs, medical devices and equipment have become victims, and are included in the scope of tariff increase, which is a direct impact. Although Trump temporarily pressed the 90-day suspension button, the universal 10% tariffs still exist, which puts pressure on the medical devices and equipment industry; while pharmaceuticals (finished drugs) escaped in 4/5 and were included in the initial exemption list, but with the U.S. about to release a new report of the National Safety Investigation Recommendations for Imported Drugs and APIs, it seems to be forecasting the initiation of an investigation into the importation of drugs, which will pave the way for the U.S. to impose tariffs on pharmaceuticals. However, with the upcoming release of the new "Recommendations for National Safety Investigations of Imported Pharmaceuticals and Pharmaceutical Ingredients" report, it seems to be a preview of the initiation of the investigation of pharmaceutical imports, which will pave the way for the U.S. to impose tariffs on pharmaceuticals.